Why this status
- 9 Feb 2022: Trial registered, NCT05230758
- 1 Jul 2022: Trial started, NCT05230758
The trials
NCT05230758: Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
- State
- Under way
- Phase
- Phase 3
- People
- 140 planned
- Started
- 1 Jul 2022
- Primary completion
- 30 Nov 2027
- Arms
- Metformin
- Results
- None posted
- 9 Feb 2022: Trial registered
- 1 Jul 2022: Trial started
How the status changed
- 19 Nov 2026: First set: Phase 3 trial
About the treatment
Kind of treatment: Drug.
Also known as Apophage, Benofomin, Diabefagos, Diabex, Extended Release Metformin Hydrochloride, Fortamet, Glucaminol, Glucophage, Glucophage xr, Glucovance component metformin hydrochloride, Glumetza, Invokamet component metformin hydrochloride, Janumet component metformin hydrochloride, Kazano component metformin hydrochloride, Metformin XR, Metformin hydrochloride (HCl) 500mg tablet, Neodipa, Qternmet component metformin hydrochloride, Qternmet xr component metformin hydrochloride, Riomet, Riomet er, Segluromet component metformin hydrochloride, Siamformet, Trijardy xr component metformin hydrochloride, Walaphage, Xigduo component metformin hydrochloride, Zituvimet component metformin hydrochloride.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.